Volume has never been a problem for Amazon Prime Video, which has a wide selection of films across all genres, including drama movies. Quality, however, remains an ongoing issue. Not everything on ...

8x8, a customer experience platform provider, has launched 8x8 Omni Shield Self-Service, a no-code SMS fraud protection tool that helps businesses detect, monitor, and block threats like artificially ...

The Mighty Argo Cable Car gondola, just north of Clear Creek in Idaho Springs, is one step closer to completion with the lower terminal nearly fully built and visible from Interstate 70. At the top of ...

8x8 Omni Shield helps businesses detect and block SMS fraud in real time — without developer resources 8x8, Inc. (NASDAQ: EGHT), one of the industry’s most integrated customer experience (CX) platform ...

AMSTERDAM—Calrec introduced a 48-faced Argo M and showcased its largest Argo software updates at the recently concluded IBC2025. Completing the Argo M range and the Argo family, the new console ...

The change of seasons is coming soon, and that means it's time for fall festivals. This weekend brings Argo's Farm's Fall fest, featuring a corn maze, hay slide, farm animals, a zipline, wagon and ...

Dramatic video shows the moment nearly 70 shipping containers fell off a cargo ship Tuesday and were left bobbing in the ocean at the Port of Long Beach in California. The containers were stationed at ...

An Argo CD vulnerability allows API tokens with even low project-level get permissions to access API endpoints and retrieve all repository credentials associated with the project. The flaw, tracked ...

NEW YORK – Argo Biopharmaceutical this week said it inked new strategic collaboration agreements for Novartis to license multiple cardiovascular siRNA assets in its pipeline. Under the terms of the ...

Gilead Sciences' Kite Pharma has cut off a collaboration with Shoreline Biosciences, ending a research collaboration on off-the-shelf cell therapies that was valued at more than $2.3 billion. The deal ...

Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...